Opening Asia for Russia

Turkey to start production of Sputnik V vaccine

23.01.2021 126 просмотров

The Russian Direct Investment Fund (RDIF) has agreed on the production of the Sputnik V coronavirus vaccine in Turkey, and has begun the process of technology transfer, a representative of the fund told TASS.

“RDIF signed an agreement with a leading Turkish pharmaceutical manufacturer to produce the Sputnik V vaccine in Turkey and began the technology transfer process. Interaction with the company is carried out as part of the RDIF's activities to promote the Sputnik V vaccine to foreign markets,” the fund reports.

The RDIF representative called the potential production volume millions of doses of the vaccine per year. He noted that the issue of a possible expansion of production in the future is also being discussed.

Sputnik V will be delivered both to the domestic market of Turkey and to other countries, the fund added, noting the great interest in the vaccine from Turkish partners.

Sputnik V is based on a proven and well-studied human adenoviral vector platform, the vaccine has already received regulatory approval in Russia, UAE, Palestine, Turkmenistan, Belarus, Hungary, Argentina, Serbia, Bolivia, Algeria, Venezuela and Paraguay. EU vaccine registration process initiated.

Новости партнёров

Подпишитесь на рассылки Большой Азии

Подпишитесь и не пропускайте эксклюзивные новости